Skip to main content

Advertisement

Table 3 Wound repair rate (%) after different TESE grafting in a time manner

From: Preclinical study of mouse pluripotent parthenogenetic embryonic stem cell derivatives for the construction of tissue-engineered skin equivalent

  3 days 6 days 9 days 12 days 15 days 18 days
No cell 19.77 ± 2.46 29.31 ± 7.46 41.34 ± 8.22 59.57 ± 3.10 69.05 ± 2.26 79.38 ± 0.76
Fibroblasts 23.14 ± 4.28 34.09 ± 3.81 50.87 ± 2.34 66.85 ± 4.98 80.5 ± 3.10 92.92 ± 1.96
eMSCs 20.71 ± 1.66 36.12 ± 1.02 53.32 ± 1.98 71.91 ± 2.63 77.01 ± 0.52 89.20 ± 0.71
pMSCs 19.70 ± 3.23 30.86 ± 7.14 50.59 ± 6.03 69.25 ± 4.12 80.06 ± 2.74 90.20 ± 0.78
  1. Data presented as mean ± SD
  2. eMSC mesenchymal stem cell derived from embryonic stem cell, pMSC mesenchymal stem cell derived from parthenogenetic embryonic stem cell, TESE tissue-engineered skin equivalents